サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：低侵襲緑内障手術用デバイスの世界市場：2022年～2029年
市場調査レポート
商品コード
1082810

低侵襲緑内障手術用デバイスの世界市場：2022年～2029年

Global Minimally Invasive Glaucoma Surgery Devices Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 190 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
低侵襲緑内障手術用デバイスの世界市場：2022年～2029年
出版日: 2022年06月03日
発行: DataM Intelligence
ページ情報: 英文 190 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の低侵襲緑内障手術用デバイスの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 世界の低侵襲緑内障手術用デバイス市場：調査手法・調査範囲

第2章 世界の低侵襲緑内障手術用デバイス市場：市場の定義と概要

第3章 世界の低侵襲緑内障手術用デバイス市場：エグゼクティブサマリー

第4章 世界の低侵襲緑内障手術用デバイス市場：市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界の低侵襲緑内障手術用デバイス市場：産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制分析

第6章 世界の低侵襲緑内障手術用デバイス市場：COVID-19の分析

  • COVID-19：市場への影響分析
  • COVID-19渦中の価格ダイナミクス
  • 需給スペクトル
  • パンデミック時の政府の市場関連イニシアチブ
  • 製造業者の戦略的イニシアチブ
  • 総論

第7章 世界の低侵襲緑内障手術用デバイス市場：製品別

  • 低侵襲緑内障手術用ステント
  • 低侵襲緑内障手術用シャント
  • その他

第8章 世界の低侵襲緑内障手術用デバイス市場：タイプ別

  • 小柱
  • 脈絡膜
  • 結膜下

第9章 世界の低侵襲緑内障手術用デバイス市場：手術タイプ別

  • 白内障を伴う緑内障
  • 緑内障のみ

第10章 世界の低侵襲緑内障手術用デバイス市場：エンドユーザー別

  • 眼科病院
  • 外来手術センター
  • 眼科クリニック
  • その他

第11章 世界の低侵襲緑内障手術用デバイス市場：地域別

  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ

第12章 世界の低侵襲緑内障手術用デバイス市場：競合情勢

  • 主な展開・戦略
  • 企業シェア分析
  • 製品ベンチマーキング

第13章 世界の低侵襲緑内障手術用デバイス市場：企業プロファイル

  • Ivantis Inc
  • Glaukos Corporation
  • Lumenis Ltd
  • Novartis
  • Ellex Medical Lasers
  • BVI
  • ASICO
  • Allcon
  • Katalystsurgical
  • IOPtima

第14章 世界の低侵襲緑内障手術用デバイス市場：DataM

目次
Product Code: DMMD5232

Market Overview

The global minimally invasive glaucoma surgery devices market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

For the treatment of glaucoma patients, minimally invasive glaucoma surgery devices provide an ab interno technique that avoids medication and conjunctival invasion. Minimally Invasive Glaucoma Surgery devices, such as stents, shunts, and micro-implants, treat individuals with mild-to-moderate glaucoma.

Market Dynamics

Over the years, there has been an increase in the preference for minimally invasive glaucoma surgery devices over traditional glaucoma surgical equipment. The former devices are safer and more effective than traditional devices. Furthermore, market participants' increased attention to developing stents specifically for minimally invasive glaucoma procedures that can reduce intraocular pressure (IOP) significantly fuels market growth.

Increasing adoption of minimally invasive surgeries over open surgeries will drive the market growth

The minimally invasive glaucoma surgery market is likely to expand due to an increase in the number of cataract and glaucoma procedures. Because of their high procedural volume, these devices are widely employed in surgeries. Furthermore, product approvals for glaucoma surgery instruments are projected to drive segment growth. Glaukos Corporation got FDA approval for the iStent, a minimally invasive glaucoma surgical drainage device used in cataract procedures. Furthermore, another business, Ivantis, gained permission for the Hydrus Microstent (MIGS device) I 2018. These gadgets are effective in glaucoma procedures, accelerating the segment's growth.

The rise in the geriatric population, combined with an increase in the prevalence of glaucoma worldwide, a surge in demand for combined glaucoma and cataract procedures, and an increase in the focus of key manufacturers on the development of MIGS stents, are driving market expansion. Furthermore, AbbVie bought Allergan plc in 2019 for eye care products such as Xen, durysta, ozurdex, and refresh/optive. With these significant improvements, regional players aim for a foothold in the minimally invasive glaucoma surgery device market. As a result, increased usage of minimally invasive glaucoma surgery devices drives market growth.These factors are likely to boost the minimally invasive glaucoma surgery devices market.

Lack of solutions for difficult anatomies is likely to hamper the market growth

However, reimbursement constraints for MIGS devices and a scarcity of experienced specialists impede market expansion.

COVID-19 Impact Analysis

The COVID-19 pandemic is an unusual worldwide public health concern expected to harm the market for minimally invasive glaucoma surgery (MIGS) equipment. For glaucoma surgery, glaucoma specialists favor the trabeculectomy operation. In minimally invasive glaucoma surgery (MIGS) before the COVID-19 epidemic, the iStent inject was the most often done MIGS procedure, followed by XEN and Preserflo. Although trabeculectomy is still the most regularly done established glaucoma surgery, it is being performed less during the COVID-19 pandemic due to a reduction in the number of postoperative visits and procedures required.

Segment Analysis

The trabecular meshwork segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The trabecular meshwork segment is expected to grow significantly during the forecast period due to ineffective drug delivery in glaucoma medication, which has prompted the transition of glaucoma treatment from medication to minimally invasive glaucoma surgery (MIGS) devices, thereby augmenting the market growth. Furthermore, market growth is fueled by introducing new products into the market. For example, On April 2017, Alcon announced the European introduction of the CyPass® Micro-Stent, a micro-invasive glaucoma surgical device designed to reduce intraocular pressure (IOP) in patients with primary open-angle glaucoma. As a result, various market players' number of regulatory authority approvals for products is boosting the market growth.

Geographical Analysis

North America region holds the largest market share of the global minimally invasive glaucoma surgery devices market

North America is likely to hold a substantial market position in the global glaucoma surgery devices market because of the increasing prevalence of glaucoma, expanding elderly population, increased awareness, favorable reimbursement policies, and several key competitors. According to a Glaucoma Research Foundation report published in 2018, an estimated 3 million people have glaucoma, which is expected to rise in the following years. Furthermore, the expanding senior population in the United States increases the risk of glaucoma. Furthermore, rising healthcare expenditures and well-established healthcare infrastructure are propelling the total regional market to new heights.

In addition, organic and inorganic strategies such as mergers and acquisitions and partnerships within key market players will strengthen their product portfolio in the studied market which will drive the market. Also, several product launches in the market will lead to lucrative growth of the market. For instance, in June 2019, Micro Surgical Technology (MST) has released the MST 19-gauge Ahmed Micro-Stent Cutter in partnership with glaucoma and cataract specialist Ike Ahmed, MD. Furthermore, advancements in various surgical devices from established key players, in the United States, are likely to drive the market growth in North America.

Competitive Landscape

The minimally invasive glaucoma surgery devices market is a highly competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Glaukos Corporation, Ivantis Inc, Lumenis Ltd, Novartis, Ellex Medical Lasers, BVI, ASICO, Alco, Katalystsurgical, IOPtima, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the minimally invasive glaucoma surgery devices market globally. For instance, In November 2019, Glaukos Corporation announced the acquisition of Avedro, Inc., a company that likewise develops products for corneal health. This acquisition has resulted in a broadening of the product line. This increased the company's revenue.

Ivantis

Overview:

Ivantis is working on a new glaucoma treatment that incorporates eye drops, laser therapy, and surgery.

Product Portfolio:

Hydrus Microstent: A doctor uses small incisions and modern equipment to place the very flexible Hydrus Microstent, roughly an eyelash size. This less invasive approach to glaucoma surgery results in fewer problems and faster healing times than traditional glaucoma surgery.

Why Purchase the Report?

Visualize the composition of the global minimally invasive glaucoma surgery devices market segmentation by product, type, surgery type, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global minimally invasive glaucoma surgery devices market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global minimally invasive glaucoma surgery devices market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global minimally invasive glaucoma surgery devices market report would provide access to an approximately 40+ market data table, 45+ figures, and in the range of 180-200 (approximate) pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Minimally Invasive Glaucoma Surgery Devices Market- By Product

Minimally Invasive Glaucoma Surgery Stents

Minimally Invasive Glaucoma Surgery Shunts

Others (Trabectome/Micro-implants/Micro-catheters)

Global Minimally Invasive Glaucoma Surgery Devices Market- By Types

Trabecular

Suprachoroidal

Subconjunctival

Global Minimally Invasive Glaucoma Surgery Devices Market- By Surgery Type

Glaucoma in conjunction with cataract

Stand Alone Glaucoma

Global Minimally Invasive Glaucoma Surgery Devices Market- By End User

Ambulatory Surgical Centers

Ophthalmology Clinics

Eye Hospitals

Others

Global Minimally Invasive Glaucoma Surgery Devices Market- By Region

North America

Europe

Asia-Pacific

Middle East & Africa

South America

Table of Contents

1. Global Minimally Invasive Glaucoma Surgery Devices Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Minimally Invasive Glaucoma Surgery Devices Market-Market Definition and Overview

3. Global Minimally Invasive Glaucoma Surgery Devices Market- Executive Summary

  • 3.1. Market Snippet By Product
  • 3.2. Market snippet By Types
  • 3.3. Market snippet By Surgery Type
  • 3.4. Market Snippet By End User
  • 3.5. Market Snippet by Region

4. Global Minimally Invasive Glaucoma Surgery Devices Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing adoption of minimally invasive surgeries over open surgeries
      • 4.1.1.2. Rising Prevalence of Glaucoma Diseases
    • 4.1.2. Restraints:
      • 4.1.2.1. Alternative treatment methods availability.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Minimally Invasive Glaucoma Surgery Devices Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. Global Minimally Invasive Glaucoma Surgery Devices Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Minimally Invasive Glaucoma Surgery Devices Market- By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
    • 7.1.2. Market Attractiveness Index, By Product Segment
  • 7.2. Minimally Invasive Glaucoma Surgery Stents*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Minimally Invasive Glaucoma Surgery Shunts
  • 7.4. Others

8. Global Minimally Invasive Glaucoma Surgery Devices Market- By Types

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Types
    • 8.1.2. Market Attractiveness Index, By Types
  • 8.2. Trabecular*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Suprachoroidal
  • 8.4. Subconjunctival

9. Global Minimally Invasive Glaucoma Surgery Devices Market- By Surgery Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 9.1.2. Market Attractiveness Index, By Surgery Type
  • 9.2. Glaucoma in conjunction with cataract*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Stand-Alone Glaucoma

10. Global Minimally Invasive Glaucoma Surgery Devices Market- By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Eye Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Ophthalmology Clinics
  • 10.5. Others

11. Global Minimally Invasive Glaucoma Surgery Devices Market- By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Types
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Types
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Types
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Global Minimally Invasive Glaucoma Surgery Devices Market- Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Global Minimally Invasive Glaucoma Surgery Devices Market- Company Profiles

  • 13.1. Ivantis Inc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Glaukos Corporation
  • 13.3. Lumenis Ltd
  • 13.4. Novartis
  • 13.5. Ellex Medical Lasers
  • 13.6. BVI
  • 13.7. ASICO
  • 13.8. Allcon
  • 13.9. Katalystsurgical
  • 13.10. IOPtima

LIST NOT EXHAUSTIVE

14. Global Minimally Invasive Glaucoma Surgery Devices Market- DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us